Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP964046.RAJELCqt2twlupwyAmTiDmwP_0MFhLBlEjMTTkRnWNpMY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP964046.RAJELCqt2twlupwyAmTiDmwP_0MFhLBlEjMTTkRnWNpMY130_assertion type Assertion NP964046.RAJELCqt2twlupwyAmTiDmwP_0MFhLBlEjMTTkRnWNpMY130_head.
- NP964046.RAJELCqt2twlupwyAmTiDmwP_0MFhLBlEjMTTkRnWNpMY130_assertion description "[The prevalence of CCDC104 antibodies was approximately similar in patients with cancer (8 of 756, 1.1%) and in healthy blood donors (2 of 300, 0.7%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP964046.RAJELCqt2twlupwyAmTiDmwP_0MFhLBlEjMTTkRnWNpMY130_provenance.
- NP964046.RAJELCqt2twlupwyAmTiDmwP_0MFhLBlEjMTTkRnWNpMY130_assertion evidence source_evidence_literature NP964046.RAJELCqt2twlupwyAmTiDmwP_0MFhLBlEjMTTkRnWNpMY130_provenance.
- NP964046.RAJELCqt2twlupwyAmTiDmwP_0MFhLBlEjMTTkRnWNpMY130_assertion SIO_000772 19680650 NP964046.RAJELCqt2twlupwyAmTiDmwP_0MFhLBlEjMTTkRnWNpMY130_provenance.
- NP964046.RAJELCqt2twlupwyAmTiDmwP_0MFhLBlEjMTTkRnWNpMY130_assertion wasDerivedFrom befree-20150227 NP964046.RAJELCqt2twlupwyAmTiDmwP_0MFhLBlEjMTTkRnWNpMY130_provenance.
- NP964046.RAJELCqt2twlupwyAmTiDmwP_0MFhLBlEjMTTkRnWNpMY130_assertion wasGeneratedBy ECO_0000203 NP964046.RAJELCqt2twlupwyAmTiDmwP_0MFhLBlEjMTTkRnWNpMY130_provenance.